Research in Nebraska

Biopharmaceutical research companies are conducting or have conducted nearly 2,000 clinical trials of new medicines in collaboration with the state’s university medical schools, clinical research centers and hospitals (1999 to present).

Of the nearly 2,000 clinical trials, 1,019 target the nation’s six most debilitating chronic diseases— asthma, cancer, diabetes, heart disease, mental illnesses and stroke.

Download PDF